Evidence that high-density lipoprotein cholesterol is an independent predictor of acute platelet-dependent thrombus formation

American Journal of Cardiology

Volumn 84, Issue 9, 1999, Pages 1011-1017

  Naqvi, Tasneem Z ^a   Shah, Prediman K ^a   Ivey, Pamela A ^a   Molloy, Mia D ^a   Thomas, Arun M ^a   Panicker, Sandeep ^a   Ahmed, Alaa ^b   Cercek, Bojan ^a   Kaul, Sanjay ^a  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b Specialty Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

ADULT; ANIMALS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY THROMBOSIS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; MODELS, CARDIOVASCULAR; PLATELET AGGREGATION; PROTHROMBIN; RISK FACTORS; SWINE; TUNICA MEDIA;

EID: 0032699713     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00489-0     Document Type: Article

References (21)

1. Brook J.G., Aviram M. Platelet lipoprotein interactions. Semin Thromb Hemost. 14:1988;258-265.
2. Knorr M., Locher R., Vogt E., Vetter W., Block L., Ferracin F., Lefkovits H., Prestcher A. Rapid activation of human platelets by low concentrations of low density lipoprotein via phosphatidylinositol cycle. Eur J Biochem. 172:1988;753-759.
3. Badimon J.J., Badimon L., Turitto V.T., Fuster V. Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model. Arterioscler Thromb. 11:1991;395-402.
4. Cadroy Y., Lemozy S., Diquelou A., Ferrieres J., Douste-Blazy P., Boneu B., Sakariassen K.S. Human type II hyperlipoproteinemia enhances platelet-collagen adhesion in flowing nonanticoagulated blood. Arterioscler Thromb. 13:1993;1650-1653.
5. Lacoste L., Lam J.Y., Hung J., Letchacovski G., Solymoss C.B., Waters D. Hyperlipidemia and coronary disease correction of the increased thrombogenic potential with cholesterol reduction . Circulation. 92:1995;3172-3177.
6. Tandon N.N., Hoeg J.M., Jamieson G.A. Perfusion studies on the formation of mural thrombi with cholesterol-modified and hypercholesterolemic platelets. J Lab Clin Med. 105:1985;157-163.
7. Kaul S., Naqvi T.Z., Fishbein M.C., Hutsell T.C., Molloy M.D., Cercek B., Shah P.K. Local delivery of an ultra short-acting nitric oxide releasing compound, DMHD/NO, is highly effective in inhibiting acute platelet-thrombus formation in injured arterial strips. J Cardiovasc Pharmacol Ther. 2:1997;181-194.
8. Fuster V.L., Badimon J.J., Badimon L., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 326:1992;242-250.
9. Lacoste L., Lam J.Y.T., Hung J., Waters D. Oral verapamil inhibits platelet thrombus formation in humans. Circulation. 89:1994;630-634.
10. Kinlough-Rathbone R.L., Packham M.A., Mustard J.F. Platelet aggregation. Harker L.A., Zimmerman T.S. Methods in Hematology Measurements of Platelet Function . 1983;64-91 Churchill Livingstone, New York, NY.
11. Shattil S., Cunningham M., Hoxie J. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 70:1987;307-315.
12. Kaplan K. Laboratory markers of platelet activation. Colman R.W., Hirsh J., Marder V.J., Salzman E.W. Hemostasis and Thrombosis - Basic Principles and Clinical Practice. 1994;1180-1196 JB Lippincott, Philadeplhia, PA.
13. Gordon T., Castelli W.P., Hjortland M., Kannel W., Dawber T. High density lipoprotein as a protective factor against coronary heart disease. Am J Med. 62:1977;707-714.
14. Gordon D.J., Rifkind B.M. High-density lipoprotein - the clinical implications of recent studies. N Engl J Med. 19:1989;1311-1316.
15. Kaul S., Padgett R.C., Waack B.J., Brooks R.M., Heistad D.D. Altered vascular responses to platelets from hypercholesterolemic humans. Circ Res. 72:1993;737-743.
16. Notarbartolo A., Davi G., Averna M., Barbagallo C.M., Ganci A., Giammarresi C., La Placa F.P., Patrono C. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arterioscler Thromb Vasc Biol. 15:1995;247-251.
17. Carvalho ACA, Colman RW, Lees RS. Platelet function in hyperlipoproteinemia. N Engl J Med 1974;290:434-138.
18. Parthasarathy S., Barnett J., Fong L.G. High density lipoprotein inhibits the oxidative modifications of low-density lipoprotein. Biochem Biophys Acta. 104:1990;275-283.
19. Matsuda Y., Hirata K., Inoue N., Suematsu M., Kawashima S., Akita H., Yokoyama M. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Circ Res. 72:1993;1103-1109.
20. Miller G.J. Lipoproteins and the haemostatic system in atherothrombotic disorders. Baillieres Clin Haematol. 7:1994;713-732.
21. Daae L.N., Kierulf P., Landaas S., Urdal P. Cardiovascular risk factors interactive effects of lipids, coagulation and fibrinolysis . Scand J Clin Lab Invest. 215:1993;19-27.